John C. Arthur
Corporate Officer/Principal presso HERON THERAPEUTICS, INC.
Profilo
John C.
Arthur is currently the Vice President-Manufacturing & Supply at Heron Therapeutics, Inc. He was previously the Senior Director-Manufacturing at Auspex Pharmaceuticals, Inc. and the Vice President-Manufacturing & CMC at Mast Therapeutics, Inc. Dr. Arthur holds a doctorate degree from the University of South Carolina and an undergraduate degree from Western Washington University.
Posizioni attive di John C. Arthur
| Società | Posizione | Inizio |
|---|---|---|
| HERON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
Precedenti posizioni note di John C. Arthur
| Società | Posizione | Fine |
|---|---|---|
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2016 |
| AUSPEX PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2013 |
Formazione di John C. Arthur
| University of South Carolina | Doctorate Degree |
| Western Washington University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- John C. Arthur
